The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2 , Pages 348-354 , February 2008

Systemic responses after bronchial aspirin challenge in sensitive patients with asthma

  • Joanna S. Makowska, MD, PhD

      Affiliations

    • Department of Immunology, Rheumatology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland
    • ,
  • Janina Grzegorczyk, PhD

      Affiliations

    • Department of Immunological Diagnostics, Faculty of Pharmacy, Medical University of Lodz, Lodz, Poland
    • ,
  • Barbara Bienkiewicz, MD, PhD

      Affiliations

    • Department of Immunology, Rheumatology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland
    • ,
  • Maria Wozniak, MD, PhD

      Affiliations

    • Allergy Clinic, Plock, Poland
    • ,
  • Marek L. Kowalski, MD, PhD

      Affiliations

    • Department of Immunology, Rheumatology and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland
    • Corresponding Author InformationReprint requests: Marek L. Kowalski, MD, PhD, Department of Immunology, Rheumatology and Allergy, Chair of Immunology, Medical University of Lodz, 251 Pomorska Str, 92-215 Lodz, Poland.

Received 28 March 2007 ,Revised 16 September 2007 ,Accepted 26 September 2007.

References 

  1. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003;111:913–921
  2. Jenkins C, Costello J, Hodge L. Systemic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328:434
  3. Grzelewska-Rzymowska I, Rozniecki J, Szmidt M, Kowalski ML. Asthma with aspirin intolerance: clinical entity or coincidence of nonspecific bronchial hyperreactivity and aspirin intolerance. Allergol Immunopathol (Madr). 1981;9:533–538
  4. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000;16:432–436
  5. Samter M, Beers RF. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68:975–983
  6. Szczeklik A, Stevenson DD. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118:773–786
  7. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89:474–478
  8. Kowalski ML, Makowska JS. Aspirin-exacerbated respiratory disease- an update on diagnosis and management. Allergy and Clin Immunol. 2006;18:140–149
  9. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ. 1975;1:67–69
  10. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–226
  11. Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy. 1996;26:807–814
  12. Kumlin M, Dahlen B, Bjorck T, Zetterstrom O, Granstrom E, Dahlen SE. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis. 1992;146:96–103
  13. Nizankowska E, Bestynska-Krypel A, Cmiel A, Szczeklik A. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J. 2000;15:863–869
  14. Swierczynska M, Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A. Nasal versus bronchial and nasal response to oral aspirin challenge: clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J Allergy Clin Immunol. 2003;112:995–1001
  15. Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy. 1985;15:411–418
  16. Sehmi R, Wood LJ, Watson R, Foley R, Hamid Q, O'Byrne PM, et al. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects: a novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest. 1997;100:2466–2475
  17. Dorman SC, Sehmi R, Gauvreau GM, Watson RM, Foley R, Jones GL, et al. Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med. 2004;169:565–572
  18. Gauvreau GM, Wood LJ, Sehmi R, Watson RM, Dorman SC, Schleimer RP, et al. The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med. 2000;162:2139–2144
  19. Sehmi R, Dorman S, Baatjes A, Watson R, Foley R, Ying S, et al. Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunology. 2003;109:536–546
  20. Lumry WR, Curd JG, Zeiger RS, Pleskow WW, Stevenson DD. Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol. 1983;71:580–587
  21. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol. 1977;60:276–284
  22. Park HS. Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. Clin Exp Allergy. 1995;25:38–40
  23. Bochenek G, Nizankowska E, Gielicz A, Swierczynska M, Szczeklik A. Plasma 9α, 11β-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax. 2004;59:459–464
  24. Nasser S, Christie PE, Pfister R, Sousa AR, Walls A, Schmitz-Schumann M, et al. Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects. Thorax. 1996;51:64–70
  25. Tomaz EM, Ferreira MF, Spinola MA, Oliveira ML, Clode MH, Palma-Carlos AG. Nasal provocation tests in the diagnosis of urticaria induced by acetylsalicylic acid. Allergy Asthma Proc. 1997;18:319–322
  26. Radinger M, Johansson AK, Sitkauskiene B, Sjostrand M, Lotvall J. Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure. J Allergy Clin Immunol. 2004;113:1109–1116
  27. Stirling RG, van Rensen EL, Barnes PJ, Chung KF. Interleukin-5 induces CD34(+) eosinophil progenitor mobilization and eosinophil CCR3 expression in asthma. Am J Respir Crit Care Med. 2001;164:1403–1409
  28. Li J, Saito H, Crawford L, Inman MD, Cyr MM, Denburg JA. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology. 2005;11:386–396
  29. Robinson DS, North J, Zeibecoglou K, Ying S, Meng Q, Rankin S, et al. Eosinophil development and bone marrow and tissue eosinophils in atopic asthma. Int Arch Allergy Immunol. 1999;118:98–100
  30. Pods R, Ross D, van Hulst S, Rudack C, Maune S. RANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triad. Allergy. 2003;58:1165–1170
  31. Christie PE, Tagari P, Ford-Hutchinson AW, Black C, Markendorf A, Schmitz-Schumann M, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143:1025–1029
  32. Kumlin M, Dahlen B, Bjorck T, Zetterstrom O, Granstrom E, Dahlen SE. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis. 1992;146:96–103
  33. Parameswaran K, Watson R, Gauvreau GM, Sehmi R, O'Byrne PM. The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma. Am J Respir Crit Care Med. 2004;169:915–920

 Supported by research grant #3PO5A12325 from the National Research Committee.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01833-7

doi: 10.1016/j.jaci.2007.09.039

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 2 , Pages 348-354 , February 2008

Article Tools

* Image Usage & Resolution